Skip to main content

Endovascular Recanalization of Thromboangiitis Obliterans (Buerger’s Disease) in Twenty-Eight Consecutive Patients and Combined Antegrade–Retrograde Intervention in Eight Patients

Abstract

Purpose

The aim of the study was to evaluate the technical success of the procedure and the clinical efficacy of treatment in patients with thromboangiitis obliterans (TAO) (Buerger’s disease) based on a change in the Rutherford classification.

Materials and Methods

A total of 28 consecutive patients (26 males, 2 females, mean age 43.3 ± 5.32 years) underwent endovascular recanalization with a diagnosis of TAO, between April 2015 and July 2018. After unsuccessful attempts using the antegrade approach, retrograde approaches were used in 8 patients under ultrasound guidance. Clinical follow-up was routinely performed at 1-month, 3-month, 6-month, and 1-year intervals.

Results

A total of 28 TAO patients underwent 40 procedures in 32 limbs. Technical success was achieved in 28 of the 32 limbs (87.5%). In total, 45 of 59 (76.2%) below the knee arteries were treated successfully. One major amputation was performed, providing a 96.8% rate for limb salvage both at 12 and 24 months. Amputation-free survival estimated by Kaplan–Meier analysis was 84% at 12 and 24 months. Primary patency rates at 12, 24, and 36 months were 84%, 78%, and 75%, respectively. Secondary patency rates were 87.5% both at 12 and 24 months.

Conclusion

Endovascular treatment is a technically feasible and potentially effective treatment modality for Buerger’s disease. Combined antegrade and retrograde interventions in TAO patients may improve technical success and clinical recovery, especially in cases where the antegrade approach has failed.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

References

  1. Olin JW. Thromboangiitis obliterans (Buerger’s disease). N Engl J Med. 2000;343:864–9.

    Article  CAS  PubMed  Google Scholar 

  2. Shionoya S. Diagnostic criteria of Buerger’s disease. Int J Cardiol. 1998;66(suppl 1):S243–5.

    Article  PubMed  Google Scholar 

  3. Piazza G, Creager MA. Thromboangiitis obliterans. Circulation. 2010;121:1858–61.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Arkkila PE. Thromboangiitis obliterans (Buerger’s disease). Orphanet J Rare Dis. 2006;1:14.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Puéchal X, Fiessinger JN. Thromboangiitis obliterans or Buerger’s disease: challenge for the rheumatologist. Rheumatology. 2007;46:192–9.

    Article  PubMed  Google Scholar 

  6. Suzuki S, Mine H, Umehara I, Yoshida T, Okada Y. Buerger’s disease (thromboangiitis obliterans): an analysis of the arteriograms of 119 cases. Clin Radiol. 1982;33:235–40.

    Article  CAS  PubMed  Google Scholar 

  7. Papa MZ, Rabi I, Adar R. A point scoring system for the clinical diagnosis of Buerger’s disease. Eur J Vasc Endovasc Surg. 1996;11:335–59.

    Article  CAS  PubMed  Google Scholar 

  8. Fujii Y, Soga J, Nakamura S, et al. Classification of corkscrew collaterals in thromboangiitis obliterans (Buerger’s disease): relationship between corkscrew type and prevalence of ischemic ulcers. Circ J. 2010;74(8):1684–8.

    Article  PubMed  Google Scholar 

  9. Olin JW, Young JR, Graor RA, Ruschhaupt WF, Bartholomew JR. The changing clinical spectrum of thromboangiitis obliterans (Buerger’s disease). Circulation. 1990;82:IV3-8.

    PubMed  Google Scholar 

  10. Mills JL. Buerger’s disease in the 21st century: diagnosis, clinical features, and therapy. Semin Vasc Surg. 2003;16:179–89.

    Article  PubMed  Google Scholar 

  11. Neufang A, Vargas-Gomez C, Ewald P, Vitolianos N, Coskun T, Abu-Salim N, et al. Very distal vein bypass in patients with thromboangiitis obliterans. Vasa. 2017;46:304–9.

    Article  PubMed  Google Scholar 

  12. Graziani L, Morelli L, Parini F, Franceschini L, Spano P, Calza S, et al. Clinical outcome after extended endovascular recanalization in Buerger’s disease in 20 consecutive cases. Ann Vasc Surg. 2012;26:387–95.

    Article  PubMed  Google Scholar 

  13. Bozkurt AK, Cengiz K, Arslan C, et al. A stable prostacyclin analogue (iloprost) in the treatment of Buerger’s disease: a prospective analysis of 150 patients. Ann Thorac Cardiovasc Surg. 2013;19:120–5.

    Article  PubMed  Google Scholar 

  14. Fazeli B, Rezaee S. A review on thromboangiitis obliterans pathophysiology: thrombosis and angiitis, which is to blame? Vascular. 2011;19:141–53.

    Article  PubMed  Google Scholar 

  15. Kröger K. Buerger’s disease: what has the last decade taught us? Eur J Intern Med. 2006;17:227–34.

    Article  PubMed  Google Scholar 

  16. Rivera-Chavarría IJ, Brenes-Gutiérrez JD. Thromboangiitis obliterans (Buerger’s disease). Ann Med Surg (Lond). 2016;7:79–82.

    Article  Google Scholar 

  17. Seebald J, Gritters L. Thromboangiitis obliterans (Buerger disease). Radiol Case Rep. 2015;10:9–11.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Hemsinli D, Altun G, Kaplan ST, et al. Hyperbaric oxygen treatment in thromboangiitis obliterans: a retrospective clinical audit. Diving Hyperb Med. 2018;48(1):31–5.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Talwar S, Jain S, Porwal R, et al. Pedicled omental transfer for limb salvage in Buerger’s disease. Int J Cardiol. 2000;72(2):127–32.

    Article  CAS  PubMed  Google Scholar 

  20. Bozkurt A, Köksal C, Demirbas M, Erdogan A, Rahman A, Demirkiliç U, et al. A randomized trial of intravenous iloprost (a stable prostacyclin analogue) versus lumbar sympathectomy in the managment of Buerguer’s disease. Int Angiol. 2006;25:162–8.

    CAS  PubMed  Google Scholar 

  21. Guo J, Guo L, Cui S, et al. Autologous bone marrow-derived mononuclear cell therapy in Chinese patients with critical limb ischemia due to thromboangiitis obliterans: 10-year results. Stem Cell Res Ther. 2018;9(1):43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Bozkurt AK, Beşirli K, Köksal C. Surgical treatment of Buerger’s disease. Vascular. 2004;12(3):192–7.

    Article  PubMed  Google Scholar 

  23. Kim DH, Ko YG, Ahn CM, et al. Immediate and late outcomes of endovascular therapy for lower extremity arteries in Buerger disease. J Vasc Surg. 2018;67(6):1769–77.

    Article  PubMed  Google Scholar 

  24. Dargon P, Landry G. Buerger’s disease. Ann Vasc Surg. 2012;26:871–80.

    Article  PubMed  Google Scholar 

  25. Lee CY, Choi K, Kwon H, et al. Outcomes of endovascular treatment versus bypass surgery for critical limb ischemia in patients with thromboangiitis obliterans. PLoS ONE. 2018;13(10):1–10.

    Google Scholar 

  26. Kawarada O, Kume T, Ayabe S, et al. Endovascular therapy outcomes and intravascular ultrasound findings in thromboangiitis obliterans (Buerger’s disease). J Endovasc Ther. 2017;24(4):504–15.

    Article  PubMed  Google Scholar 

  27. Modaghegh MS, Hafezi S. Endovascular treatment of thromboangiitis obliterans (Buerger’s disease). Vasc Endovasc Surg. 2018;52(2):124–30.

    Article  Google Scholar 

  28. Becker GJ, Katzen BT, Dake MD. Noncoronary angioplasty. Radiology. 1989;170:921–40.

    Article  CAS  PubMed  Google Scholar 

  29. Bosiers M, Hart JP, Deloose K, Verbist J, Peeters P. Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: experience with 443 infrapopliteal procedures. Vascular. 2006;14(2):63–9.

    Article  PubMed  Google Scholar 

  30. Papavassiliou VG, Walker SR, Bolia A, Fishwick G, London N. Techniques for the endovascular management of complications following lower limb percutaneous transluminal angioplasty. Eur J Vasc Endovasc Surg. 2003;25(2):125–30.

    Article  CAS  PubMed  Google Scholar 

  31. Pernès JM, Auguste M, Borie H, et al. Infrapopliteal arterial recanalization: a true advance for limb salvage in diabetics. Diagn Interv Imaging. 2015;96(5):423–34.

    Article  PubMed  Google Scholar 

  32. El-Sayed H, Bennett ME, Loh TM, Davies MG. Retrograde Pedal access and endovascular revascularization: a safe and effective technique for high-risk patients with complex tibial vessel disease. Ann Vasc Surg. 2016;31:91–8.

    Article  PubMed  Google Scholar 

  33. Montero-Baker M, Schmidt A, Braunlich S, et al. Retrograde approach for complex popliteal and tibioperoneal occlusions. J Endovasc Ther. 2008;15:594–604.

    Article  PubMed  Google Scholar 

  34. Rogers RK, Dattilo PB, Garcia JA, et al. Retrograde approach to recanalization of complex tibial disease. Catheter Cardiovasc Interv. 2011;77:915–25.

    Article  PubMed  Google Scholar 

  35. Kilickesmez O, Oguzkurt L. Mechanical thrombectomy with Rotarex system in Buerger’s disease. J Clin Imaging Sci. 2015;5:14.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ali Firat.

Ethics declarations

Conflict of interest

The author declares that he has no conflict of interest.

Ethical Approval

The ethical committee approval is not required since the study is retrospective.

Informed Consent

Informed consent was obtained from all participants.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Firat, A., Igus, B. Endovascular Recanalization of Thromboangiitis Obliterans (Buerger’s Disease) in Twenty-Eight Consecutive Patients and Combined Antegrade–Retrograde Intervention in Eight Patients. Cardiovasc Intervent Radiol 42, 820–828 (2019). https://doi.org/10.1007/s00270-019-02193-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-019-02193-x

Keywords

  • Buerger’s disease
  • Thromboangiitis obliterans
  • Angioplasty
  • Endovascular
  • Limb ischemia